dPCR AND qPCR MARKET SIZE TO CROSS USD 8 BILLION BY 2025, GROWING AT A CAGR OF 9% DURING THE FORECAST PERIOD

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share, & Trends Analysis Report By Technology (Real-Time PCR and Digital PCR), Product (Systems/Analyzers & Software and Consumables), Application (Clinical, Research, and Forensic), End-user (Hospitals, Diagnostic Laboratories, Research Laboratories, Pharma & Biotech Companies, Forensic Laboratories, and Others), and Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

262 Pages

icon-table

66 Tables

icon-chart

120 Charts

icon-region

5 Regions

icon-country

19 Countries

icon-company

46 Companies

icon-market

5 Market Segment

GLOBAL Digital PCR (dPCR) and Real-time PCR (qPCR) MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 8 BILLION (2025)
CAGR 9 % (2020-2025)
Base Year 2019
Forecast Year 2020–2025
Market Segments Technology (Real Time PCR and Digital PCR), Product (Systems/Analyzers & Software and Consumables), Application (Clinical, Research, and Forensic), End-user (Hospitals, Diagnostic Laboratories, Research Laboratories, Pharma & Biotech Companies, Forensic Laboratories, and Others)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, and Turkey

INDUSTRY INSIGHTS

The global Digital PCR (dPCR) and Real-time PCR (qPCR) market size are to be valued at USD 8 billion by the end of 2025, growing at a CAGR of over 9% during the forecast period. The digital PCR market size is expected to grow at a CAGR of over 11.5% during the forecast period. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing segments in the diagnostic and life sciences industries. The dPCR and the qPCR market are growing at a significant rate due to the rising incidence of infectious diseases and genetic disorders, continuous technological advancements in PCR technologies, the successful completion of the human genome project, and increasing R&D investments, funds, and grants as well as the increasing use of biomarker profiling for disease diagnostics. The surge in the growth can also be attributed to the growing prevalence/incidence of epidemics and pandemics such as the COVID-19 pandemic.

The introduction of automated analyzers with advanced connectivity, and high throughput, reduced waiting time and portability, the increase in the accuracy of the devices with the usage of the PCR specific test kits, ability to perform a large volume of tests in a shorter duration of time are expected to influence the market. Moreover, continued efforts by manufacturers to develop novel dPCR and qPCR systems and kits to use in molecular testing are likely to further propel the growth of the dPCR and qPCR market. New systems are expected to offer highly automated workflows and quick turnaround times than the current digital PCR platforms, which are likely to provide a significant competitive advantage.

SNIPPETS

  • The digital PCR segment is expected to grow at a CAGR of over 11.5% during the forecast period as dPCRs are increasingly replacing real-time PCRs in the human genome project.
  • The consumable segment is likely to reach a revenue share of close to $6 billion by 2025 due to the recurring usage of consumables for performing PCR tests.
  • The clinical end-user segment is projected to observe an incremental growth of close to $1.8 billion by 2025 on account of the effective detection of bacteria by real-time PCR assays.
  • The diagnostic segment is expected to grow at the highest CAGR of 10% during the period 2019–2025 due to the widespread application of PCR assays in diagnostic laboratories.
  • The APAC region is likely to register the fastest CAGR of over 11% during the period 2019–2025 because of increased government support, awareness of advanced, accurate diagnosis PCR assays, and the high prevalence of infectious diseases.

GLOBAL dPCR AND qPCR MARKET SEGMENTATION

This research report market includes a detailed segmentation by

  • Technology
  • Product
  • Application
  • End-user
  • Geography

INSIGHTS BY TECHNOLOGY 

In 2019, the Real-time PCR (qPCR) segment dominated the market and accounted for a share of over 90%. One of the major reasons for the dominance of qPCRs is that they are widely used in infectious disease diagnosis and research projects. Real-time PCRs (qPCRs) has been well-established as credible and capable technology and are relied upon by researchers for their speed, sensitivity, specificity, and convenience. Several laboratories in developing countries are upgraded their infrastructure and technical training to perform PCR-based diagnosis for infectious diseases, thereby driving the segment growth.

The Digital PCR (dPCR) segment is slowly gaining momentum in the market, and dPCRs are accepted as an advanced technology among researchers. dPCRs are replacing qPCR in the human genome project and other sequencing studies and ongoing cancer research. In the current scenario, both technologies play a vital role in the market. PCR technologies as a whole – real-time and digital – show significant promise for driving growth in the future. While qPCR products continue to serve a real purpose in research labs, dPCR impressive levels of sensitivity, precision, robustness, and reproducibility are helping researchers propel their work beyond previous limits.

INSIGHTS BY PRODUCT

The usage of a wide array of several standard reagents and test kits to perform several PCR-based tests is a significant factor responsible for the growth of the consumable segment. The usage of consumables is reoccurring in nature, generating continuous revenue for vendors. Therefore, several renowned vendors are manufacturing consumables for PCR instruments. In recent years, the demand for consumables has been increasing at a significant rate; hence, vendors are offering a wide array of reagents and other associated consumables to perform a range of procedures. Both global and local/regional players offer a diverse range of consumables catering to the end-users requirements. The high prevalence of several infectious diseases across the globe has increased the demand for PCRs.

The instrument segment includes both Digital PCR (dPCR) and Real-time PCR (qPCR), which are used to perform multiple tests in pharma and biotech, research labs, diagnostic labs, academic institutes, etc. As the demand for instruments is growing, vendors are coming with several new technologies which offer connectivity, remote access, portability, and automation. As the life span of analyzers and other equipment is higher, they do not require repetitive purchase. Vendors consider them as a one-time investment from end-users. The sale of the latest instruments/analyzers is higher in developed countries than in developing and underdeveloping countries. Several emerging economies such as China, India, and Brazil are observing an increased uptake of diagnostics equipment such as PCR, which is likely to influence the market segment.

INSIGHTS BY APPLICATION

The clinical end-user segment dominates the market as PCRs play a significant role in detecting DNA methylation, recognizing viruses and protozoa in infectious diseases, estimating of gene copy number aberrations, and primer extension. The application of qPCR is high in the clinical application end-user segment due to the high cost of dPCR. As real-time PCR assays offer immediate results for the detection of bacteria, clinicians can confirm the infection status of the patient more rapidly than culture methods, allowing more specific and timely administration of appropriate therapy. The research application segment is limited to users in developed countries. The segment accounted for a share of over 44% in the global dPCR and qPCR market. Gene expression, genotyping, sequencing cloning, mutagenesis, and methylation are the major applications for PCRs in the research segment.

INSIGHTS BY END-USER

Diagnostic laboratories are the largest end-user of PCR instruments and consumables than other segments. They use PCR instruments for diagnosis purposes. Commercial and public health laboratories prefer the latest diagnostic equipment. Their investment focuses on advanced equipment for accurate results to attract customers. Private laboratories have expanded their footprints, especially in developing countries, which has stimulated growth prospects. Moreover, the demand for standalone reference laboratories is growing gradually owing to the prevalence of pandemic conditions, or the outbreak of unexpected infectious diseases, requiring immediate diagnosis of the diseases for the large population in a shorter period.

In 2019, the hospital segment accounted for a share of over 23% in the global dPCR and qPCR market. Laboratories are the exclusive units in hospitals. Around 92% of hospitals operate with their own laboratories. They are one of the largest end-users of PCR instruments and consumables as these settings perform a wide range of diagnostics testing. The availability of skilled healthcare professionals with knowledge and expertise in treating and diagnosing such conditions also attracts more patients to hospitals than in other healthcare settings, thereby influencing the digital PCR and real-time PCR market share.

INSIGHTS BY GEOGRAPHY

In 2019, North America accounted for a market share of 45% of the global digital PCR (dPCR) and real-time PCR (qPCR) market. Several factors are responsible for the growth of the market in the region. However, the increase in the target population and the high incidence of several infectious disease diagnostics are driving the PCR demand. There has been increasing in the prevalence of sexually transmitted diseases in North America. In 2018, over 37,832 people were confirmed HIV positive in the US and other states. A significant increase in several infectious diseases such as hepatitis, TB, and HIV was reported in the US alone. Approximately every 3 minutes, one person in the US is diagnosed with blood cancer. An estimated 176,200 people in the United States are diagnosed with leukemia, lymphoma, or myeloma in 2019. The government expenditure on clinical diagnostics & laboratory services has grown by 3% during the period 2010–2017, reaching $96.6 billion. Advances in technology are likely to increase the role of PCR tests in detecting, treating, and monitoring diseases. PCR is widely used in hospital setups as the conventional technique of culture-based disease diagnosis requires long isolation time and hospital admission.

INSIGHTS BY VENDORS

The global Digital PCR (dPCR) and Real-time PCR (qPCR) market is highly dynamic with the presence of global, regional, and local players, offering a diverse range of analyzers, software, and reagents for end-users. Agilent Technologies, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, QIAGEN, Takara Biotech, and Thermo Fisher Scientific are the key players operating in the global dPCR and qPCR market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers are continuously focusing on product launches & development and offering PCR instruments and software with new features to increase their market presence.

Vendors are focusing on developing and commercializing innovative analyzers, dPCR, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the market. New product approvals/launches coupled with R&D activities help vendors to expand their presence, enhance market growth during the forecast period, and sustain their market position in the global qPCR and dPCR market.

The Digital PCR (dPCR) and Real-time PCR (qPCR) market research report include in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

By Product

  • Systems/Analyzers & Software
  • Consumables

By Application

  • Clinical
  • Research
  • Forensic

By Technology

  • Real-Time PCR
  • Digital PCR

By End-user

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Pharma & Biotech Companies
  • Forensic Laboratories
  • Others

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey

Frequently Asked Questions

What is the Digital PCR (dPCR) and Real-time PCR (qPCR) market size in 2020?

The global dPCR and qPCR market size to cross revenues of over USD 8 billion by the end of 2025, growing at aCAGR of over 9% during the forecast period.

What are the factors impacting the growth of the dPCR and qPCR market share?

The following factors are likely to contribute to the growth of the dPCR and qPCR market during the forecast period: • Surge in Demand for PCR Tests due to COVID-19 • Increase in Demand for POC PCR Diagnostics • Prevalence of Infectious Disease and Genetic Disorder • Advances in PCR Technology

What is the growth of the digital PCR market?

The digital PCR segment is expected to grow at a CAGR of over 11.5% during the forecast period.

Who are the leading vendors in the dPCR and qPCR market, and what are their market shares?

Agilent Technologies, Bio-Rad laboratories, Danaher, F. Hoffmann-La Roche, QIAGEN, Takara Biotech, and Thermo Fisher Scientific are the key players operating in the global dPCR and qPCR market.

What is the impact of the COVID-19 pandemic on the dPCR and qPCR market share?

Vendors are focusing on developing and commercializing innovative analyzers, dPCR, COVID-19 PCR rapid test kits and consumables to remain competitive and gain a significant presence in the market.

Download Free Sample

The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025.

The following factors are likely to contribute to the growth of the dPCR and qPCR market during the forecast period:

  • Surge in Demand for PCR Tests due to COVID-19
  • Increase in Demand for POC PCR Diagnostics
  • Prevalence of Infectious Disease and Genetic Disorder
  • Advances in PCR Technology

Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the dPCR and qPCR market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Agilent Technologies Inc.
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Quidel
  • QIAGEN
  • Takara Bio
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Danaher
  • F.Hoffmann-La Roche

Other Prominent Vendors 

  • Abbott
    • Business Overview
    • Product Offerings
  • BD
  • bioMérieux
  • Convergent Technologies
  • FLUIDIGM
  • Promega
  • Analytik Jena Group
  • Meridian Bioscience
  • Eppendorf
  • Enzo Life Sciences
  • BIONEER
  • ELITechGroup
  • Quantabio
  • Sacace Biotechnologies
  • Bio Molecular Systems
  • Biomeme
  • JN Medsys
  • Anitoa Systems
  • ACTGene
  • Mylab Discovery Solutions
  • Amplyus
  • Blue-Ray Biotech
  • PentaBase
  • Hologic
  • GenMark Diagnostics
  • Luminex
  • Mobidiag
  • PathoFinder
  • Acupath Laboratories
  • ALTRU DIAGNOSTICS
  • Altona Diagnostics
  • BGI
  • BioCore
  • Fosun Pharma
  • General Biologicals Corporation (GBC)
  • GeneStore
  • Gnomegen
  • KogeneBiotech

Segmentation by Product

  • Systems/Analyzers & Software
  • Consumables

Segmentation by Application

  • Clinical
  • Research
  • Forensic

Segmentation by Technology

  • Real Time PCR (qPCR)
  • Digital PCR (dPCR)

Segmentation by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Pharma & Biotech Companies
  • Forensic Laboratories
  • Others

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope Of The Study

4.3.1 Market Segmentation by Technology

4.3.2 Market Segmentation by Product

4.3.3 Market Segmentation by Application

4.3.4 Market Segmentation by End-User

4.3.5 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

7.1.1 Evolution of PCR

7.2 COVID-19 Pandemic

7.2.1 Overview

8 Market Opportunities & Trends

8.1 Surge In The Demand For PCR Tests Due To Covid-19

8.2 Increase In The Demand For Point-Of-Care (POC) PCR Diagnostics

8.3 Paradigm Shift Towards The Usage Of dPCR

9 Market Growth Enablers

9.1 Increase In The Prevalence Of Infectious Diseases And Genetic Disorders

9.2 Technological Advancements In PCR

9.3 Expanding Application Of PCR Post Human Genome Project

10 Market Restraints

10.1 Technical Limitations Of PCR

10.2 High Cost Of PCR

10.3 Low Penetration Of PCR Instruments In LMICs

11 Market Landscape

11.1 Market Overview

11.2 Market Size & Forecast

11.3 Five Forces Analysis

11.3.1 Threat of New Entrants

11.3.2 Bargaining Power of Suppliers

11.3.3 Bargaining Power of Buyers

11.3.4 Threat of Substitutes

11.3.5 Competitive Rivalry

12 Technology

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Real-Time PCR

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Digital PCR

12.4.1 Market Overview

12.4.2 Market Size & Forecast

13 Product

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Consumables

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.4 Systems/Analyzers & Software

13.4.1 Market Overview

13.4.2 Market Size & Forecast

14 Application

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Clinical Applications

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.4 Research Applications

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.5 Forensic Applications

14.5.1 Market Overview

14.5.2 Market Size & Forecast

15 End-User

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Diagnostic Laboratories

15.3.1 Market Overview

15.3.2 Market Size & Forecast

15.4 Hospitals

15.4.1 Market Overview

15.4.2 Market Size & Forecast

15.5 Research Laboratories

15.5.1 Market Overview

15.5.2 Market Size & Forecast

15.6 Pharma & Biotech Companies

15.6.1 Market Overview

15.6.2 Market Size & Forecast

15.7 Forensic Laboratories

15.7.1 Market Overview

15.7.2 Market Size & Forecast

15.8 Others

15.8.1 Market Overview

15.8.2 Market Size & Forecast

16 Geography

16.1 Market Snapshot & Growth Engine

16.2 Geographic Overview

17 North America

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 US: Market Size & Forecast

17.3.2 Canada: Market Size & Forecast

18 Europe

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 Germany: Market Size & Forecast

18.3.2 France: Market Size & Forecast

18.3.3 UK: Market Size & Forecast

18.3.4 Italy: Market Size & Forecast

18.3.5 Spain: Market Size & Forecast

19 APAC

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Key Countries

19.3.1 Japan: Market Size & Forecast

19.3.2 China: Market Size & Forecast

19.3.3 Australia: Market Size & Forecast

19.3.4 South Korea: Market Size & Forecast

19.3.5 India: Market Size & Forecast

20 Latin America

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Key Countries

20.3.1 Brazil : Market Size & Forecast

20.3.2 Mexico: Market Size & Forecast

20.3.3 Argentina: Market Size & Forecast

21 Middle East And Africa

21.1 Market Overview

21.2 Market Size & Forecast

21.3 Key Countries

21.3.1 Turkey: Market Size & Forecast

21.3.2 Saudi Arabia: Market Size & Forecast

21.3.3 South Africa: Market Size & Forecast

21.3.4 UAE: Market Size & Forecast

22 Competitive Landscape

22.1 Competition Overview

22.2 Market Share Analysis

22.2.1 Agilent Technologies

22.2.2 Bio-Rad Laboratories

22.2.3 Danaher

22.2.4 F. Hoffmann-La Roche

22.2.5 Quidel

22.2.6 Qiagen

22.2.7 Takara Bio

22.2.8 Thermo Fisher Scientific

23 Key Company Profiles

23.1 Agilent Technologies

23.1.1 Business Overview

23.1.2 Product Offerings

23.1.3 Key Strategies

23.1.4 Key Strengths

23.1.5 Key Opportunities

23.2 Quidel

23.2.1 Business Overview

23.2.2 Product Offerings

23.2.3 Key Strategies

23.2.4 Key Strengths

23.2.5 Key Opportunities

23.3 Qiagen

23.3.1 Business Overview

23.3.2 Product Offerings

23.3.3 Key Strategies

23.3.4 Key Strengths

23.3.5 Key Opportunities

23.4 Takara Bio

23.4.1 Business Overview

23.4.2 Product Offerings

23.4.3 Key Strategies

23.4.4 Key Strengths

23.4.5 Key Opportunities

23.5 Thermo Fisher Scientific

23.5.1 Business Overview

23.5.2 Product Offerings

23.5.3 Key Strategies

23.5.4 Key Strengths

23.5.5 Key Opportunities

23.6 Bio-Rad Laboratories

23.6.1 Business Overview

23.6.2 Product Offerings

23.6.3 Key Strategies

23.6.4 Key Strengths

23.6.5 Key Opportunities

23.7 Danaher

23.7.1 Business Overview

23.7.2 Product Offerings

23.7.3 Key Strategies

23.7.4 Key Strengths

23.7.5 Key Opportunities

23.8 F. Hoffmann-La Roche

23.8.1 Business Overview

23.8.2 Product Offerings

23.8.3 Key Strategies

23.8.4 Key Strengths

23.8.5 Key Opportunities

24 Other Prominent Vendors

24.1 Abbott

24.1.1 Business Overview

24.1.2 Product Offerings

24.2 BD

24.2.1 Business Overview

24.2.2 Product Offerings

24.3 bioMérieux

24.3.1 Business Overview

24.3.2 Product Offerings

24.4 Convergent Technologies

24.4.1 Business Overview

24.4.2 Product Offerings

24.5 FLUIDIGM

24.5.1 Business Overview

24.5.2 Product Offerings

24.6 Promega

24.6.1 Business Overview

24.6.2 Product Offerings

24.7 Analytik Jena Group

24.7.1 Business Overview

24.7.2 Product Offerings

24.8 Meridian Bioscience

24.8.1 Business Overview

24.8.2 Product Offerings

24.9 Eppendorf

24.9.1 Business Overview

24.9.2 Product Offerings

24.10 Enzo Life Sciences

24.10.1 Business Overview

24.10.2 Product Offerings

24.11 Bioneer

24.11.1 Business Overview

24.11.2 Product Offerings

24.12 ELITechGroup

24.12.1 Business Overview

24.12.2 Product Offerings

24.13 Quantabio

24.13.1 Business Overview

24.13.2 Product Offerings

24.14 SACACE Biotechnologies

24.14.1 Business Overview

24.14.2 Product Offerings

24.15 Bio Molecular Systems

24.15.1 Business Overview

24.15.2 Product Offerings

24.16 Biomeme

24.16.1 Business Overview

24.16.2 Product Offerings

24.17 JN Medsys

24.17.1 Business Overview

24.17.2 Product Offerings

24.18 Anitoa Systems

24.18.1 Business Overview

24.18.2 Product Offerings

24.19 ACTGene

24.19.1 Business Overview

24.19.2 Product Offerings

24.20 Mylab Discovery Solutions

24.20.1 Business Overview

24.20.2 Product Offerings

24.21 Amplyus

24.21.1 Business Overview

24.21.2 Product Offerings

24.22 Blue-Ray Biotech

24.22.1 Business Overview

24.22.2 Product Offerings

24.23 PentaBase

24.23.1 Business Overview

24.23.2 Product Offerings

24.24 Hologic

24.24.1 Business Overview

24.24.2 Product Offerings

24.25 GenMark Diagnostics

24.25.1 Business Overview

24.25.2 Product Offerings

24.26 Luminex

24.26.1 Business Overview

24.26.2 Product Offerings

24.27 Mobidiag

24.27.1 Business Overview

24.27.2 Product Offerings

24.28 PathoFinder

24.28.1 Business Overview

24.28.2 Product Offerings

24.29 Acupath Laboratories

24.29.1 Business Overview

24.29.2 Product Offerings

24.30 ALTRU Diagnostics

24.30.1 Business Overview

24.30.2 Product Offerings

24.31 Altona Diagnostics

24.31.1 Business Overview

24.31.2 Product Offerings

24.32 BGI

24.32.1 Business Overview

24.32.2 Product Offerings

24.33 BioCore

24.33.1 Business Overview

24.33.2 Product Offerings

24.34 Fosun Pharma

24.34.1 Business Overview

24.34.2 Product Offerings

24.35 GenerAl Biologicals

24.35.1 Business Overview

24.35.2 Product Offerings

24.36 GeneStore

24.36.1 Business Overview

24.36.2 Product Offerings

24.37 Gnomegen

24.37.1 Business Overview

24.37.2 Product Offerings

24.38 KogeneBiotech

24.38.1 Business Overview

24.38.2 Product Offerings

25 Report Summary

25.1 Key Takeaways

25.2 Strategic Recommendations

26 Quantitative Summary

26.1 Market By Geography

26.2 Market By End-User

26.3 Market By Technology

26.4 Market By Product

26.5 Market By Application

27 Appendix

27.1 Abbreviations

List Of Exhibits 

Exhibit 1               Segmentation of Global qPCR and dPCR Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Impact of Surge in the Demand for PCR Tests due to COVID-19

Exhibit 4               Number of Tests Conducted in Various Key Countries – (As of June 2020 - millions)

Exhibit 5               Impact of Increase in the Demand for POC PCR Diagnostics

Exhibit 6               Impact of Paradigm Shift towards the Usage of dPCR

Exhibit 7               Impact of Increase in the Prevalence of Infectious Diseases and Genetic Disorders

Exhibit 8               Global Number of Human Infectious Disease Outbreak and Pathogen Taxonomy (past four decades comparison)

Exhibit 9               Impact of Technological Advancements in PCR

Exhibit 10             Impact of Expanding Application of PCR Post Human Genome Project

Exhibit 11             Impact of Technical Limitations of PCR

Exhibit 12             Impact of High Cost of PCR

Exhibit 13             Impact of Low Penetration of PCR Instruments in LMICs

Exhibit 14             Availability of the Healthcare Service

Exhibit 15             Global qPCR and dPCR Market 2019–2025 ($ million)

Exhibit 16             Five Forces Analysis 2019

Exhibit 17             Incremental Growth by Technology 2019 & 2025

Exhibit 18             Global qPCR and dPCR Market by Technology

Exhibit 19             Global qPCR and dPCR Market by Technology: Incremental Growth

Exhibit 20             Global qPCR and dPCR Market by Technology: Absolute Growth

Exhibit 21             Global qPCR and dPCR Market by Real-Time PCR: Incremental Growth versus Absolute Growth

Exhibit 22             Global qPCR and dPCRMarket– Real-Time PCR 2019–2025 ($ million)

Exhibit 23             Global qPCR and dPCR Market by Digital PCR: Incremental Growth versus Absolute Growth

Exhibit 24             Global qPCR and dPCR Market – Digital PCR 2019–2025 ($ million)

Exhibit 25             Incremental Growth by Product 2019 & 2025

Exhibit 26             Global qPCR and dPCR Market by Product

Exhibit 27             Global qPCR and dPCR Market by Product: Incremental Growth

Exhibit 28             Global qPCR and dPCR Market by Product: Absolute Growth

Exhibit 29             Global qPCR and dPCR Market by Consumables: Incremental Growth versus Absolute Growth

Exhibit 30             Global qPCR and dPCR Market - Consumables 2019–2025 ($ million)

Exhibit 31             Global qPCR and dPCR Market by Systems/Analyzers & Software: Incremental Growth versus Absolute Growth

Exhibit 32             Global qPCR and dPCR Market – Systems/Analyzers & Software 2019–2025 ($ million)

Exhibit 33             Incremental Growth by Application 2019 & 2025

Exhibit 34             Global qPCR and dPCR Market by Application

Exhibit 35             Global qPCR and dPCR Market by Application: Incremental Growth

Exhibit 36             Global qPCR and dPCR Market by Application: Absolute Growth

Exhibit 37             Global qPCR and dPCR Market by Clinical Applications: Incremental Growth versus Absolute Growth

Exhibit 38             Global qPCR and dPCR - Clinical Applications 2019–2025 ($ million)

Exhibit 39             Global qPCR and dPCR Market by Research Applications: Incremental Growth versus Absolute Growth

Exhibit 40             Global qPCR and dPCR - Research Applications 2019–2025 ($ million)

Exhibit 41             Workflow in Forensic DNA Analysis

Exhibit 42             Global qPCR and dPCR - Forensic Applications 2019–2025 ($ million)

Exhibit 43             Incremental Growth by End-user 2019 & 2025

Exhibit 44             Global qPCR and dPCR Market by End-User

Exhibit 45             Global qPCR and dPCR Market by End-User: Incremental Growth

Exhibit 46             Global qPCR and dPCR Market by End-User: Absolute Growth

Exhibit 47             Global qPCR and dPCR Market by Diagnostic Laboratories: Incremental Growth versus Absolute Growth

Exhibit 48             Global qPCR and dPCR Market- Diagnostic Laboratories 2019–2025 ($ million)

Exhibit 49             Global qPCR and dPCR Market by Hospitals: Incremental Growth versus Absolute Growth

Exhibit 50             Global qPCR and d PCR Market- Hospitals 2019–2025 ($ million)

Exhibit 51             Global qPCR and dPCR Market by Research Laboratories: Incremental Growth versus Absolute Growth

Exhibit 52             Global qPCR and dPCR Market- Research Laboratories 2019–2025 ($ million)

Exhibit 53             Global qPCR and dPCR Market by Pharma and Biotech Companies: Incremental Growth versus Absolute Growth

Exhibit 54             Global qPCR and d PCR Market- Pharma and Biotech Companies 2019–2025 ($ million)

Exhibit 55             Global qPCR and dPCR Market by Forensic Laboratories: Incremental Growth versus Absolute Growth

Exhibit 56             Global qPCR and d PCR Market – Forensic Laboratories 2019–2025 ($ million)

Exhibit 57             Global qPCR and dPCR Market by Others: Incremental Growth versus Absolute Growth

Exhibit 58             Global qPCR and d PCR Market- Others 2019–2025 ($ million)

Exhibit 59             Incremental Growth by Geography 2019 & 2025

Exhibit 60             Global qPCR and dPCR Market by Geography

Exhibit 61             Global qPCR and dPCR Market by Geography: Incremental Growth

Exhibit 62             Global qPCR and dPCR Market by Geography: Absolute Growth

Exhibit 63             Real-time PCR and Digital PCR Market in North America: Key Countries 2019 ($ million)

Exhibit 64             Real-time PCR and Digital PCR Market in North America: Incremental Growth versus Absolute Growth Comparison

Exhibit 65             qPCR and dPCR Market in North America 2019–2025 ($ million)

Exhibit 66             Incremental Growth in North America 2019 & 2025

Exhibit 67             US Laboratory Types and Test Volumes

Exhibit 68             qPCR and dPCR Market in US 2019–2025 ($ million)

Exhibit 69             qPCR and dPCR Market in Canada 2019–2025 ($ million)

Exhibit 70             Real-time PCR and Digital PCR Market in Europe: Key Countries 2019 ($ million)

Exhibit 71             Real-time PCR and Digital PCR Market in Europe: Incremental Growth versus Absolute Growth Comparison

Exhibit 72             qPCR and dPCR Market in Europe 2019–2025 ($ million)

Exhibit 73             Incremental Growth in Europe 2019 & 2025

Exhibit 74             qPCR and dPCR Market in Germany 2019–2025 ($ million)

Exhibit 75             qPCR and dPCR Market in France 2019–2025 ($ million)

Exhibit 76             qPCR and dPCR PCR Market in UK 2019–2025 ($ million)

Exhibit 77             qPCR and dPCR Market in Italy 2019–2025 ($ million)

Exhibit 78             qPCR and dPCR Market in Spain 2019–2025 ($ million)

Exhibit 79             Real-time PCR and Digital PCR Market in APAC: Key Countries 2019 ($ million)

Exhibit 80             Real-time PCR and Digital PCR Market in APAC: Incremental Growth versus Absolute Growth Comparison

Exhibit 81             qPCR and dPCR Market in APAC 2019–2025 ($ million)

Exhibit 82             Incremental Growth in APAC 2019 & 2025

Exhibit 83             qPCR and d PCR Market in Japan 2019–2025 ($ million)

Exhibit 84             qPCR and dPCR Market in China 2019−2025($ million)

Exhibit 85             qPCR and dPCR Market in Australia 2019−2025($ million)

Exhibit 86             qPCR and dPCR Market in South Korea 2019–2025 ($ million)

Exhibit 87             qPCR and dPCR Market in India 2019−2025($ million)

Exhibit 88             Real-time PCR and Digital PCR Market in Latin America: Key Countries 2019 ($ million)

Exhibit 89             Real-time PCR and Digital PCR Market in Latin America: Incremental Growth versus Absolute Growth Comparison

Exhibit 90             qPCR and d PCR Market in Latin America 2019–2025 ($ million)

Exhibit 91             Incremental Growth in Latin America 2019 & 2025

Exhibit 92             qPCR and dPCR Market in Brazil 2019–2025 ($ million)

Exhibit 93             qPCR and d PCR Market in Mexico 2019–2025 ($ million)

Exhibit 94             qPCR and dPCR Market in Argentina 2019–2025 ($ million)

Exhibit 95             Real-time PCR and Digital PCR Market in Middle East and Africa: Key Countries 2019 ($ million)

Exhibit 96             Real-time PCR and Digital PCR Market in Middle East and Africa: Incremental Growth versus Absolute Growth Comparison

Exhibit 97             qPCR and dPCR Market in Middle East and Africa 2019–2025 ($ million)

Exhibit 98             Incremental Growth in Middle East & Africa 2019 & 2025

Exhibit 99             qPCR and d PCR Market in Turkey 2019–2025 ($ million)

Exhibit 100          qPCR and dPCR Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 101          qPCR and dPCR Market in South Africa 2019–2025 ($ million)

Exhibit 102          qPCR and dPCR Market in UAE 2019–2025 ($ million)

Exhibit 103          Agilent Technologies Revenue by Business Segment 2017−2019 ($ million)

Exhibit 104          Agilent Technologies Total Revenue 2017−2019 ($ million)

Exhibit 105          Agilent Technologies - Research and Development Expenses 2017−2019 ($ million)

Exhibit 106          QIAGEN Total Revenue 2017−2019 ($ million)

Exhibit 107          QIAGEN Research and Development Expenditure 2017−2019 ($ million)

Exhibit 108          QIAGEN Revenue by Product Categories 2017−2019 ($ million)

Exhibit 109          Takara Bio Revenue 2017−2019 ($ million)

Exhibit 110          Takara Bio R&D Expenditure 2017−2019 ($ million)

Exhibit 111          Thermo Fisher Scientific: Revenue 2017−2019 ($ million)

Exhibit 112          Thermo Fisher Scientific: R&D Expenditure 2017−2019 ($ million)

Exhibit 113          Thermo Fisher Scientific: Revenue by Geography ($ million)

Exhibit 114          Bio-Rad Laboratories Revenue 2017−2019 (billion)

Exhibit 115          Danaher: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 116          Danaher: Net Sales 2017−2019 ($ million)

Exhibit 117          Danaher: Revenue by Geography 2019

Exhibit 118          Danaher: R&D Expenditure 2017−2019 ($ million)

Exhibit 119          F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)

Exhibit 120          F. Hoffmann-La Roche: Revenue by Geographical Segment 2018 & 2019 ($ billion)

               

               

List Of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  List of Few POC PCR Equipment

Table 4                  List of Significant Vendors offering PCR in the Market

Table 5                  Cost of PCR Machines

Table 6                  Cost of PCR Machines based on blocks

Table 7                  Cost Comparison of Traditional Microbiological technique and PCR Technology

Table 8                  Applications and Advantages of Real-Time PCR

Table 9                  Applications and Advantages of Digital PCR

Table 10               List of PCR Consumables

Table 11               Agilent Technologies: Major Product Offerings

Table 12               Quidel: Major Product Offerings

Table 13               Qiagen: Major Product Offerings

Table 14               Takara Bio: Major Product Offerings

Table 15               Thermo Fisher Scientific: Major Product Offerings

Table 16               Bio-Rad Laboratories: Major Product Offerings

Table 17               Danaher: Major Product Offerings

Table 18               F. Hoffmann-La Roche: Major Product Offerings

Table 19               ABBOTT: Major Product Offerings

Table 20               BD: Major Product Offerings

Table 21               bioMérieux: Major Product Offerings

Table 22               Convergent Technologies: Major Product Offerings

Table 23               FLUIDIGM: Major Product Offerings

Table 24               Promega: Major Product Offerings

Table 25               Analytik Jena Group: Major Product Offerings

Table 26               Meridian Bioscience: Major Product Offerings

Table 27               Eppendorf: Major Product Offerings

Table 28               Enzo Life Sciences: Major Product Offerings

Table 29               BIONEER: Major Product Offerings

Table 30               ELITechGroup: Major Product Offerings

Table 31               Quantabio: Major Product Offerings

Table 32               Sacace Biotechnologies: Major Product Offerings

Table 33               Bio Molecular Systems: Major Product Offerings

Table 34               Biomeme: Major Product Offerings

Table 35               JN Medsys: Major Product Offerings

Table 36               Anitoa Systems: Major Product Offerings

Table 37               ACTGene: Major Product Offerings

Table 38               Mylab Discovery Solutions: Major Product Offerings

Table 39               Amplyus: Major Product Offerings

Table 40               Blue-Ray Biotech Major Product Offerings

Table 41               PentaBase: Major Product Offerings

Table 42               Hologic: Major Product Offerings

Table 43               GenMark Diagnostics: Major Product Offerings

Table 44               Luminex: Major Product Offerings

Table 45               Mobidiag: Major Product Offerings

Table 46               PathoFinder: Major Product Offerings

Table 47               Acupath Laboratories: Major Product Offerings

Table 48               ALTRU DIAGNOSTICS: Major Product Offerings

Table 49               Altona Diagnostics: Major Product Offerings

Table 50               BGI: Major Product Offerings

Table 51               BioCore: Major Product Offerings

Table 52               Fosun Pharma: Major Product Offerings

Table 53               General Biologicals: Major Product Offerings

Table 54               GeneStore: Major Product Offerings

Table 55               Gnomegen: Major Product Offerings

Table 56               KogeneBiotech: Major Product Offerings

Table 57               Global qPCR and dPCR Market by Geography 2019−2025 ($ million)

Table 58               Global qPCR and dPCR Market by Geography 2019−2025 (%)

Table 59               Global qPCR and dPCR Market by End-User 2019−2025 ($ million)

Table 60               Global qPCR and dPCR Market by End-User 2019−2025 (%)

Table 61               Global qPCR and dPCR Market by Technology 2019−2025 ($ million)

Table 62               Global qPCR and dPCR Market by Technology 2019−2025 (%)

Table 63               Global qPCR and dPCR Market by Product 2019−2025 ($ million)

Table 64               Global qPCR and dPCR Market by Product 2019−2025 (%)

Table 65               Global qPCR and dPCR Market by Application 2019−2025 ($ million)

Table 66               Global qPCR and dPCR Market by Application 2019−2025 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date